Skip to main content

LOGAN CAPITAL MANAGEMENT INC

Position in GSK — GSK plc

CIK 1121330 Newtown Square, PA

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,395,203
+$7,395,203 QoQ
Shares Held
141,076
Ownership
0.007%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#128
of 1,032 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Derivatives in GSK

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$6,939,589
PutShares
125,740

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. GSK ranks #8 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GSK
GSK plc
This page
141,076 $7,395,203

All Filings in GSK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,395,203 141,076
2026-03-31 $6,939,589 125,740
2025-12-31 $5,635,528 114,917
2025-09-30 $4,507,069 104,427
2025-06-30 $3,618,969 94,244
2025-03-31 $3,337,798 86,159
2024-12-31 $2,863,302 84,663
2024-09-30 $3,430,771 83,923
2024-06-30 $3,112,340 80,840
2024-03-31 $3,574,886 83,389
2023-12-31 $2,948,048 79,548
2023-09-30 $2,778,598 76,651
2023-06-30 $2,596,266 72,847
2023-03-31 $452,007 12,704
2022-12-31 $446,417 12,704
2022-06-30 $677,983 15,880
2022-03-31 $678,450 15,880
2021-12-31 $686,861 15,880
2021-09-30 $595,274 15,884
2021-06-30 $620,356 15,884
2021-03-31 $555,875 15,880
2020-12-31 $1,432,331 39,684
2020-09-30 $1,518,482 41,132
2020-06-30 $1,587,351 39,677
2020-03-31 $1,437,630 38,685